NICE Ltd. Insider Trading

NICE

Last 12 months

Insiders sold 50K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. VP, Corporate Finance Udi Yehuda Dayan sold 50K on Aug 7, 100% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market

−50K

0 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

None

in the last two years

Get an email when NICE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 7	Udi Yehuda Dayan VP, Corporate Finance	SoldNo plan	500	$100.00	50K	100%	Form 4

Aug 7No plan
Udi Yehuda Dayan
VP, Corporate Finance · sold 500 at $100.00
50K
100% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NICE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Services-Prepackaged Software · Pick stocks to compare with NICE

CompareIntrinsic value

OKTAOkta Inc.

$191.05+0.72%65

PTCPTC Inc.

$194.92+0.44%88

NTNXNutanix, Inc.

$63.70-1.52%82

CHKPCheck Point Software Technologies Ltd.

$147.41+3.61%69

VEEVVeeva Systems Inc.

$310.64+2.45%75

DOCUDocuSign Inc.

$80.50+0.17%84

MDBMongoDB Inc.

$328.38-2.08%65

HUBSHubSpot, Inc.

$216.64-4.21%73

Held by ETFs

NICE is in 22 US ETFs. The largest of them, with NICE's weight in each:

Spot a number that looks wrong? Check it in NICE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NICE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.